» Articles » PMID: 38355908

Outcomes of Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation and the Role of Antimicrobial Prophylaxis

References
1.
Busemann C, Ribback S, Zimmermann K, Sailer V, Kiefer T, Schmidt C . Toxoplasmosis after allogeneic stem cell transplantation--a single centre experience. Ann Hematol. 2012; 91(7):1081-9. DOI: 10.1007/s00277-012-1406-5. View

2.
Montoya J, Liesenfeld O . Toxoplasmosis. Lancet. 2004; 363(9425):1965-76. DOI: 10.1016/S0140-6736(04)16412-X. View

3.
Hakko E, Ozkan H, Karaman K, Gulbas Z . Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients. Transpl Infect Dis. 2013; 15(6):575-80. DOI: 10.1111/tid.12138. View

4.
Fricker-Hidalgo H, Bulabois C, Brenier-Pinchart M, Hamidfar R, Garban F, Brion J . Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clin Infect Dis. 2008; 48(2):e9-e15. DOI: 10.1086/595709. View

5.
Martino R, Bretagne S, Einsele H, Maertens J, Ullmann A, Parody R . Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis. 2004; 40(1):67-78. DOI: 10.1086/426447. View